5 unknown. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Unknown 5 |
Follow Type 1 Diabetes: new trials by email Literature Review of Type 1 Diabetes trials Research Report on Type 1 Diabetes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Dapagliflozin in Early Diabetic Nephropathy in Type 1 Diabetes dapagliflozin, ACE inhibitor - Diabetic Kidney Disease, Type 1 Diabetes | Phase 4 | Unknown | The First Affiliated Hospital with Nanjing Medical University | 54 | 2024-07-01 | 2024-08-01 |
| Effectiveness of Empagliflozin Added to Automated Insulin Delivery (AID) Systems in Adults With Type 1 Diabetes With Sub-optimal Glycemic Outcomes Empagliflozin, Placebo - Type 1 Diabetes | Phase 4 | Unknown | McGill University Health Centre/Research Institute of the McGill University Health Centre | 46 | 2024-04-02 | 2024-08-09 |
| The Effect of Lixisenatide on the Effect of Pituitary Hormones Placebo, Lixisenatide 10 micrograms (50 micrograms/ml in 3 ml) Pen Injector - Healthy, Type 1 Diabetes | Phase 4 | Unknown | University of Tartu | 10 | 2023-04-17 | 2023-06-12 |
| Fast-Acting Insulin Aspart and Insulin Pump Settings Insulin aspart, Fast-acting insulin aspart - Type 1 Diabetes | Phase 4 | Unknown | Kirsten Nørgaard | 40 | 2021-02-01 | 2021-02-16 |
| The Effect of Saxagliptin on Glucose Fluctuation and Immune Regulation in Patients With Type 1 Diabetes Saxagliptin, Insulin - Type 1 Diabetes | Phase 4 | Unknown | Nanjing Medical University | 184 | 2014-11-01 | 2016-07-06 |
Diabetes Mellitus, Type 1 (5) · Diabetes Mellitus (1) · Diabetic Nephropathies (1)
Autoimmune Diseases (5) · Endocrine System Diseases (5) · Glucose Metabolism Disorders (5) · Immune System Diseases (5) · Metabolic Diseases (5) · Nutritional and Metabolic Diseases (5) · Diabetes Mellitus (4) · Diabetes Complications (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Urogenital Diseases (1) · Urologic Diseases (1)
Angiotensin-Converting Enzyme Inhibitors (1) · Dipeptidyl-Peptidase IV Inhibitors (1) · Insulin (1) · Insulin Aspart (1) · Sodium Chloride (1) · Solutions (1) · dapagliflozin (1) · empagliflozin (1) · lixisenatide (1) · saxagliptin (1)
Kirsten Nørgaard (1) · McGill University Health Centre/Research Institute of the McGill University Health Centre (1) · Nanjing Medical University (1) · The First Affiliated Hospital with Nanjing Medical University (1) · University of Tartu (1)
China (2) · Canada (1) · Denmark (1) · Estonia (1)
Mei Zhang (1) · Melissa-Rosina Pasqua, MD (1) · Tao Yang, MD/PhD (1) · Vallo Volke, MD, PhD (1)